108 results on '"Lorson, Christian L."'
Search Results
2. Islatravir: evaluation of clinical development for HIV and HBV
3. Red cabbage juice-mediated gut microbiota modulation improves intestinal epithelial homeostasis and ameliorates colitis
4. Potential therapeutic targets for Mpox: the evidence to date
5. Normal muscle fiber type distribution is recapitulated in aged ephrin-A3-/- mice that previously lacked most slow myofibers
6. ABT1 modifies SMARD1 pathology via interactions with IGHMBP2 and stimulation of ATPase and helicase activity
7. Mutations in the monkeypox virus replication complex: Potential contributing factors to the 2022 outbreak
8. Continued Complexity of Mutations in Omicron Sublineages
9. Complex Mutation Pattern of Omicron BA.2: Evading Antibodies without Losing Receptor Interactions
10. Motor unit recovery following Smn restoration in mouse models of spinal muscular atrophy
11. A combinatorial approach increases SMN level in SMA model mice
12. CRISPR‐Mediated Enzyme Fragment Complementation Assay for Quantification of the Stability of Splice Isoforms
13. Friend or Foe(tal): challenges in development of a large animal model for pre-clinical fetal gene therapy
14. Trans cohort metabolic reprogramming towards glutaminolysis in long-term successfully treated HIV-infection
15. Defining the optimal dose and therapeutic window in SMA with respiratory distress type I model mice, FVB/NJ-Ighmpb2
16. Gene Therapy in Spinal Muscular Atrophy (SMA) Models Using Intracerebroventricular Injection into Neonatal Mice
17. Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants
18. The Ighmbp2D564N mouse model is the first SMARD1 model to demonstrate respiratory defects
19. Evolutionary analysis of the Delta and Delta Plus variants of the SARS-CoV-2 viruses
20. The adeno-associated virus 2 genome and Rep 68/78 proteins interact with cellular sites of DNA damage
21. Trans Cohorts Metabolomic Modulation Following Long-Term Successful Therapy in HIV-Infection
22. Survival motor neuron deficiency slows myoblast fusion through reduced myomaker and myomixer expression
23. A distinct metabolic profile associated with a fatal outcome in COVID-19 patients during early epidemic in Italy
24. Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents
25. Discovery and in-vitro evaluation of potent SARS-CoV-2 entry inhibitors
26. Factors Associated with Emerging and Re-emerging of SARS-CoV-2 Variants
27. Evolution, correlation, structural impact and dynamics of emerging SARS-CoV-2 variants
28. Short-duration splice promoting compound enables a tunable mouse model of spinal muscular atrophy
29. Infectivity of SARS-CoV-2: there Is Something More than D614G?
30. AAV9-DOK7 gene therapy reduces disease severity in Smn SMA model mice
31. Minor snRNA gene delivery improves the loss of proprioceptive synapses on SMA motor neurons
32. Development of a novel severe mouse model of spinal muscular atrophy with respiratory distress type 1: FVB-nmd
33. Muscle fiber-type selective propensity to pathology in the nmd mouse model of SMARD1
34. Functional characterization of SMN evolution in mouse models of SMA
35. AAV9-mediated delivery of miR-23a reduces disease severity in Smn2B/−SMA model mice
36. A Direct Comparison of IV and ICV Delivery Methods for Gene Replacement Therapy in a Mouse Model of SMARD1
37. Self-oligomerization regulates stability of survival motor neuron protein isoforms by sequestering an SCFSlmb degron
38. Selective vulnerability in neuronal populations in nmd/SMARD1 mice
39. Optimization of a series of heterocycles as survival motor neuron gene transcription enhancers
40. Optimization of trans-Splicing for Huntington's Disease RNA Therapy
41. Analysis of Azithromycin Monohydrate as a Single or a Combinatorial Therapy in a Mouse Model of Severe Spinal Muscular Atrophy
42. Astrocyte-produced miR-146a as a mediator of motor neuron loss in spinal muscular atrophy
43. Discovery of a Small Molecule Probe That Post-Translationally Stabilizes the Survival Motor Neuron Protein for the Treatment of Spinal Muscular Atrophy
44. Comparison of independent screens on differentially vulnerable motor neurons reveals alpha-synuclein as a common modifier in motor neuron diseases
45. Plastin-3 extends survival and reduces severity in mouse models of spinal muscular atrophy
46. SMN deficiency negatively impacts red pulp macrophages and spleen development in mouse models of Spinal Muscular Atrophy
47. Retraction notice: the SMN structure reveals its crucial role in snRNP assembly
48. Self-oligomerization regulates stability of Survival Motor Neuron (SMN) protein isoforms by sequestering an SCFSlmb degron
49. Optimization of Morpholino Antisense Oligonucleotides Targeting the Intronic Repressor Element1 in Spinal Muscular Atrophy
50. Rescue of a Mouse Model of Spinal Muscular Atrophy With Respiratory Distress Type 1 by AAV9-IGHMBP2 Is Dose Dependent
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.